Conditions · Alzheimer's disease & early-stage dementia
Alzheimer's disease & early-stage dementia — clinical trials in Italy
30 open options
- TRIALNARECRUITING
EARLY-COGN^3 - Smart Digital Solutions for EARLY Treatment of COGnitive Disability: a Neuropsychological, Neurophysiological and Neurobiological Perspective in Chronic Neurological Diseases - PNRR-MCNT2-2023-12377069
RICORDO-DTx · Home-based unstructured cognitive stimulation — 3 sites
- TRIALNARECRUITING
Case-Finding for Neurocognitive Disorders in Pavia
Case-finding for Neurocognitive Disorders — 1 site
- TRIALNANOT_YET_RECRUITING
Personalized Medicine in the Elderly With Vision Impairment and Mild Cognitive Impairment
nLIFE EyeFitness — 1 site
- TRIALPHASE3RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
KarXT · Placebo — 129 sites
- TRIALNARECRUITING
Next-Generation alzheImer'S Therapeutics
genetically encoded engineered proteins — 1 site
- TRIALPHASE3RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
No Intervention — 212 sites
- TRIALPHASE3RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Xanomeline/Trospium Chloride Capsule · Xanomeline Enteric Capsule · Placebo — 145 sites
- TRIALNARECRUITING
Transcranial Pulse Stimulation. a Potential Treatment for Early Dementia
Transcranial Pulse Stimulation — 2 sites
- TRIALNARECRUITING
Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment
Mediterranean-type diet with MCT supplementation · Mediterranean-type food regimen using extra virgin olive oil — 1 site
- TRIALPHASE2 / PHASE3RECRUITING
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Remternetug (SC) · Matching Placebo (Remternetug) — 37 sites
- TRIALNARECRUITING
A Socio-Technological Intervention in Community-Based Healthcare for Individuals With Mild Cognitive Impairment (DHEAL-COM-MCI)
socio-technical intervention · Usual care — 1 site
- TRIALPHASE2 / PHASE3RECRUITING
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Remternetug · Matching Placebo (Remternetug) — 37 sites
- TRIALNARECRUITING
Personalized Digital Training for COGnitive FITness in Mild Cognitive Impairment
RICORDO · S.A.M.B.A. — 2 sites
- TRIALPHASE2 / PHASE3RECRUITING
ACP-204 in Adults With Alzheimer's Disease Psychosis
ACP-204 · Placebo — 148 sites
- TRIALNARECRUITING
MASCoD - Multidimensional Assessment of Subjective Cognitive Decline
cognitive training — 1 site
- TRIALNARECRUITING
Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors
Digital solution for the prediction of the biological mechanisms of Alzheimer's disease through the analysis of risk factors — 2 sites
- TRIALNARECRUITING
A Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia, MAINSTREAM ID:3430931
Active tDCS · individualized language training · Placebo tDCS — 4 sites
- TRIALNANOT_YET_RECRUITING
Cognitive Rehabilitation With Virtual Reality in Parkinson Disease
Cognitve rehabilitation with virtual reality and robotic arm — 1 site
- TRIALNARECRUITING
Financial Abilities in Neurological Diseases. Development of a Telerehabilitation Program: FINAGE
Telerehabilitation group · Conventioanl treatment group — 1 site
- TRIALNARECRUITING
Feasibility Study of Virtual Sail 3D in Cognitive Functions
VSail 3D · WEB-Health — 1 site
- TRIALNANOT_YET_RECRUITING
Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
Exercise · Control (Standard treatment) — 6 sites
- TRIALPHASE3RECRUITING
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Acoramidis · Placebo oral tablet — 104 sites
- TRIALNARECRUITING
Training App for Inhibitory Control Towards Food
Food-specific inhibitory control training delivered through the FoodTraining App · Waiting list — 1 site
- TRIALPHASE3ENROLLING_BY_INVITATION
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
ACP-204 — 76 sites
- TRIALNARECRUITING
Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content (PancreasPlus).
use of PancreasPlus app — 2 sites
- TRIALNAENROLLING_BY_INVITATION
The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias
Electroencephalogram · 3 Tesla MRI · Apolipoprotein E genetic test — 1 site
- TRIALNARECRUITING
Silver Agri Age: Longevity, Intrinsic Capacity and Cognitive Impairment Into Farmlands and Natural Environments: Updating Contexts Following the "Montessori" Action
Social activities with cognitive stimulation — 2 sites
- TRIALNANOT_YET_RECRUITING
Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance
MRI assessment and blood sample collection — 1 site
- TRIALNARECRUITING
Validation of a Digital Intervention to Rehabilitate Cognitive Resources
RICORDO · Treatment as Usual (TAU) — 1 site
- TRIALNARECRUITING
Effectiveness of TeleVR App in Cognitive Decline and MCI Patients
Telerehabilitation with Virtual Reality · Traditional Cognitive Rehabilitation — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.